In addition to enhanced glycolysis, mutant K-Ras is responsible for the shuttling of glycolytic intermediates to various anabolic pathways such as pentose phosphate pathway and hexosamine biosynthetic pathway, which are critical for the genesis, proliferation, and progression of pancreatic cancer (Ying et al., 2012). The gene discussed is KRAS; the disease is pancreatic neoplasm.